SEARCH

SEARCH BY CITATION

References

  • Banyai L., Tordai H., Patthy L.. The gelatin-binding site of human 72 kDa type IV collagenase (gelatinase A). Biochem J. 1994;298: 403407.
  • Bickett DM, Green MD, Berman J., Dezube M., Howe AS, Brown PJ, Roth JT, McGeehan GM. A high throughput fluorogenic substrate for interstitial collagenase (MMP-1) and gelatinase (MMP-9). Anal Biochem. 1993;212: 5864.
  • Burnette WN. “Western blotting”: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 1981;112: 195203.
  • Christensson A., Lilja H.. Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen. Eur J Biochem. 1994;220: 4553.
  • Collier IE, Krasnov PA, Strongin AY, Birkedal-Hansen H., Goldberg GI. Alanine scanning mutagenesis and functional analysis of the fibronectin-like collagen-binding domain from human 92-kDa type IV collagenase. J Biol Chem. 1992;267: 67766781.
  • Drisdel RC, Mack SR, Anderson RA, Zaneveld LJD. Purification and partial characterization of acrosome reaction inhibiting glycoprotein from human seminal plasma. Biol Reprod. 1995;53: 201208.
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227: 680685.
  • McCauley TC, Zhang HM, Bellin ME, Ax RL. Identification of a heparin-binding protein in bovine seminal fluid as tissue inhibitor of metalloproteinases-2. Mol Reprod Dev. 2001;58: 336341.
  • Minakata K., Asano M., Yonekawa O.. Cysteine proteinase inhibitor levels in semen. Clin Biochem. 1986;19: 171174.
  • Nagase H.. Matrix metalloproteinases. In: Hooper NM, ed. Zinc Metalloproteases in Health and Disease. London: Taylor and Francis Press; 1996: 153204.
  • Nagase H., Suzuki K., Cawston TE, Brew K.. Involvement of a region near valine-69 of tissue inhibitor of metalloproteinases (TIMP)-1 in the interaction with matrix metalloproteinase 3 (stromelysin 1). Biochem J. 1997;325: 163167.
  • Netzel-Arnett S., Mallya SK, Nagase H., Birkedal-Hansen H., van Wart HE. Continuously recording fluorescent assays optimized for five human matrix metalloproteinases. Anal Biochem. 1991;195: 8692.
  • Okada Y., Watanabe S., Nakanishi I., Kishi J., Hayakawa T., Watorek W., Travis J., Nagase H.. Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases. FEBS Lett. 1988;229: 157160.
  • Robert M., Gagnon C.. Semenogelin I: a coagulum forming, multifunctional seminal vesicle protein. Cell Mol Life Sci. 1999;55: 944960.
  • Schiessler H., Arnhold M., Ohlsson K., Fritz H.. Inhibitors of acrosin and granulocyte proteinases from human genital tract secretions. Hoppe-Seyler Z Physiol Chem. 1976;357: 12511260.
  • Schill WB. Quantitative determination of high molecular weight serum proteinase inhibitors in human semen. Andrologia. 1976;8: 359364.
  • Shimokawa K., Katayama M., Matsuda Y., Takahashi H., Hara I., Sato H., Kaneko S.. Matrix metalloproteinase (MMP)-2 and MMP-9 activities in human seminal plasma. Mol Hum Reprod. 2002;8: 3236.
  • Sternlicht MD, Coussens LM, Vu TH, Werb Z.. Biology and regulation of the matrix metalloproteinases. In: Clendeninn NJ, Appelt K., eds. Matrix Metalloproteinase Inhibitors in Cancer Therapy., Totowa, NJ: Humana Press; 2001: 137.
  • Wilson MJ, Norris H., Kapoor D., Woodson M., Limas C., Sinha AA. Gelatinolytic and caseinolytic proteinases activities in human prostatic secretions. J Urol. 1993;149: 653658.